PTPRC and cancer: While expansion of tumor neoantigen-specific CD8+ T cells, which contribute to cancer eradication, has been previously reported in other cancer types, we found that the sum of CD4+ T cells, B cells, and ASCs in OSCC was similar to CD8+ T cells, and CD4+ CTLs and activated B cells were the main CD45+ immune cells.